Neuranics Lab is building a blood count machine that runs by fingerprick
The Delhi-based company has developed MorphX, a point-of-care platform that claims to return a full blood count in minutes without needing a trained technician.
Nuranics Lab, a diagnostics startup founded in Delhi in 2021, is developing a compact point-of-care blood count machine called MorphX. The device aims to bypass the need for patients to provide vial blood samples and wait for results, instead offering rapid, on-site analysis through a fingerprick test. MorphX utilizes a microfluidic cartridge to process the sample and employs multi-spectral imaging combined with deep learning algorithms to analyze over 20 parameters, including cell morphology.
This approach provides a more comprehensive analysis than conventional laboratory analyzers, which typically only measure electrical properties of cells. The startup has secured funding between $700,000 and $1.48 million from several investors, including Inflection Point Ventures, Pontaq, and Venture Center. A clinical trial is underway to compare MorphX against an existing imported blood count analyzer, though results are not yet available.
Written by urgent.news from YourStory's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
